Comparison of the efficacy and safety of a 730‐nm picosecond titanium sapphire laser and a 1064‐nm picosecond neodymium yttrium aluminum garnet laser for the treatment of acquired bilateral nevus of Ota‐like macules: A split‐face, evaluator‐blinded, randomized, and controlled pilot trial

Documenti analoghi

• Wavelength‐dependent threshold fluences for melanosome disruption to evaluate the treatment of pigmented lesions with 532‐, 730‐, 755‐, 785‐, and 1064‐nm picosecond lasers
  di: Yu Shimojo, et al.
  Pubblicazione: (2024)
• Novel picosecond 755 nm alexandrite laser for treating exogenous ochronosis
  di: Rawan Almutairi, et al.
  Pubblicazione: (2024)
• Efficacy and safety of 1064‐nm fractional picosecond laser for the treatment of postmastectomy scars in transgender men: A randomized controlled trial
  di: Suthinee Rutnin, et al.
  Pubblicazione: (2024)
• Combining large‐spot low‐fluence 1064‐nm and fractional 1064‐nm picosecond lasers for promoting protective melanosome autophagy via the PI3K/Akt/mTOR signalling pathway for the treatment of melasma
  di: Jie Shen, et al.
  Pubblicazione: (2024)
• Comparison of the fractionated Nd: YAG 1064‐nm picosecond laser with holographic optics and the fractional CO2 laser in atrophic acne scar treatment: a prospective, randomized, split‐face study
  di: Yucheng Yuan, et al.
  Pubblicazione: (2024)